Kingswood Health Centre is one of the practices in South Glos that participates in approved NHS research studies through the NHS National Institute for Health Studies. As part of the National Institute for Health Research, we help to provide the infrastructure that allows high-quality clinical research to take place in the NHS, so that patients can benefit from new and better treatments, and we can learn how to improve NHS healthcare for the future.
We are committed to the Department of Health’s national strategy which puts patients at the centre of all NHS related activity. To ensure that ‘patient benefit’ is not simply based on the views and options of research professionals and clinicians, the national strategy highlights the importance of involving patients, carers and the public at all stages of the research process.
We have recently set up a cluster-wide research HUB with our neighbouring practices Hanham Health, Cadbury Heath Healthcare and Close Farm Surgery.
Patients and public can be involved:
- As patients/participants voluntarily taking part in clinical or other well designed studies.
- As patients and public members working with research professionals and clinicians (e.g. doctors, nurses) and getting actively involved in the different stages of research and related activities.
For more info see http://www.crncc.nihr.ac.uk/
If you would like to be considered for any of our studies please let your GP know.
Current research studies:
A Study to provide evidence to inform the management of chest infections in children. To estimate the effectiveness of amoxicillin overall in of children aged 6mths - 12yrs with uncomplicated lower respiratory tract infections. Parents and children who consent to the study and agree to randomization will receive either antibiotic or placebo and will be required to complete a study diary.
A study looking to see whether people who have been taking long term antidepressants have particular beliefs, attitudes, and behaviours towards their antidepressant use to manage their long-term depression.
To determine whether early treatment with a 5-day course of co-amoxiclav reduces the need for re-consultation ‘at risk’ children who present in primary care with influenza/influenza-like illness (ILI).